Injective (INJ) is performing in perfect alignment with the strategic growth scenario we outlined last week. Following a decisive breakout from the descending triangle structure and establishing a firm foothold above the 100-period Moving Average (MA100), the price candles have now covered over 40% of the path toward our 2026 macro target. The consensus of active capital flow reveals incredible intrinsic strength, transforming former technical barriers into solid steel foundations for this sustainable growth journey.
The reason for maintaining sobriety at this stage is the cyclical nature of price action. When an asset has rallied significantly without a major technical retracement, jumping in based on the fear of missing out (FOMO) exposes you to a high risk of being stopped out during short-term market volatility. For investors holding Long positions from the lower value zones, iron discipline now means proactively trailing your stop-loss to higher levels to secure your gains. In professional circles, decisive risk management is always more critical than attempting to predict the exact peak. Let your profits run, but always ensure a safety net is in place. If you are still on the sidelines, patiently await a new technical setup rather than chasing green candles once the impulse has entered a sensitive price zone and technical obstacles are neutralized.
this is not investment advice, DYOR $INJ $CHIP $SPK #Colecolen
